C60 Fullerene.

C60 has essentially no water solubility and is supplied dissolved in an oil rather than as a powder. The carrier oil determines how much stays in solution and whether the material is absorbed at all.

Olive oil, which is mostly oleic acid, is the carrier the original C60 preparations used because the fullerene cage dissolves in it over long stirring. The oil is part of the delivery form rather than an added active.

Both sit in the lipid phase and interact with radicals there, tocopherol by donating a hydrogen atom and the fullerene cage by adding radicals across its double bonds. Whether they act together beyond keeping the oil stable is not settled.

C60 carries no polar groups and will not dissolve in water, so any oral preparation depends on a lipid or amphiphile to carry it. Phospholipids from lecithin form mixed micelles that keep nonpolar solutes dispersed through the gut lumen. This is formulation chemistry rather than a measured clinical pairing.

Phosphatidylcholine is the main phospholipid of bile-derived mixed micelles, the vehicle that moves fat-soluble material across the unstirred water layer. A cage molecule with zero water solubility travels the same route as dietary lipid. No human absorption study of the pairing exists, so read it as mechanistic.

Bile acids emulsify dietary fat and are required for micellar uptake of anything that travels in the lipid phase. An oil-dispersed fullerene preparation is subject to that same dependence. People with low bile output take longer to emulsify an oil dose, which is why the pairing gets raised in formulation work.

Pancreatic lipase hydrolyses triglyceride to monoglyceride and free fatty acid, the components that build the absorptive micelle. An oil carrier only releases its cargo once that hydrolysis happens. The relationship is with the carrier oil, not with the fullerene itself.

Krill oil supplies phospholipid-bound fatty acids that emulsify readily, which is why it appears as a carrier in nonpolar formulations. Any fullerene taken with it moves in the lipid phase. There is no combination trial, so the basis is vehicle chemistry only.

C60 dissolves measurably in vegetable triglyceride oils and not at all in water, which is why oil-dissolved preparations dominate the category. Flaxseed oil works as one of those carriers. It is also highly oxidisable, so preparations built on it are usually kept cold and dark.

Both molecules sit in the lipid phase of a formulation and both accept radicals in laboratory systems. Whether that laboratory overlap produces anything additive in a person has not been measured. Read the pairing as chemistry that co-locates, not as a demonstrated combined effect.

Astaxanthin is a lipid-soluble carotenoid that quenches singlet oxygen in membrane models. A fullerene dispersed in the same oil occupies the same phase. No combination data exist in humans and the confidence stays at the bottom band for that reason.

Ascorbate works in the water phase while a fullerene sits in the lipid phase, which is the classic arrangement described for pairs of radical scavengers. The recycling relationship demonstrated for ascorbate and tocopherol has not been shown for fullerenes. What exists is an analogy, not a measurement.

Glutathione is the main intracellular thiol buffer and handles reactive species in the cytosol. Laboratory work on carbon nanomaterials repeatedly measures glutathione status as the readout, which is a marker rather than an outcome. Any pairing claim here is mechanistic and unmeasured in people.

Alpha-lipoic acid moves between water and lipid phases and regenerates other reduced species in laboratory systems. That behaviour is why it is proposed alongside lipid-phase scavengers. No study has measured the two together.

Tocotrienols terminate lipid peroxidation chains inside membranes, the same compartment an oil-carried fullerene ends up in. Formulators pair them with oxidisable carrier oils to protect the oil itself. The protective role is on the vehicle, and any benefit to the person is not established.

Quercetin is a flavonoid radical scavenger studied in the same in vitro assays that fullerene work uses. The overlap is methodological rather than clinical. Nothing has been measured about the two given together.